Device Trial Radar · NCT01643525
Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke
Last checked: Nov 19, 2026Latest source record: Jul 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
29
Actual
Start
Jun 2012
Primary completion
Dec 2012
Study completion Dec 2012
Sponsor
- Lead sponsor
- Jan Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 18, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
That the Jan Medical Nautilus NeuroWaveTM system provides significantly higher sensitivity to hyper acute ischemic stroke than does CT.
Conditions
- Ischemic Stroke
Interventions
Nautilus NeuroWaveTM SystemDevice
Non-invasive device designed to detect pressure signals from the skull to aid in the diagnosis of ischemic stroke.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Device Related Adverse EventsTime frame: 2-3 days, at subject exit (variation of subject exit date depended on when subject obtained their radiology imaging to confirm ischemic stroke)
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Johns Hopkins Hospital
Baltimore, Maryland
Johns Hopkins Bayview Medical Center
Baltimore, Maryland
Howard County General Hospital
Columbia, Maryland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.